That Medscape article might require a login. Here is a Tarsa press release that says the same thing. I have no interest in Tarsa, but I wanted to add some information to the great article from Nordic Biosciences relative to EMIS.
Novartis uses Unigenes mfg process for Oral sct. Tarsa is a joint venture which includeds MVM Life Sciences, Novo A/S Quaker Bioventure and Unigene Labs. Tarsa ran the Clinical trials using Unigenes Sct and delivery formulation.